Welcome to The Tipple! In this episode, ROM is joined by Miranda Ballard from NielsenIQ to talk about one of the biggest forces currently reshaping consumer behaviour: the rise of GLP-1 weight-loss injections.

As these treatments move into the mainstream, they’re changing how people eat, drink and think about health. Miranda shares fresh data on declining and changing food consumption across the UK and US, moving shoppers’ priorities towards nutrient density, and what this means for brands navigating a rapidly evolving market.

From cultural attitudes to health, to the commercial realities of falling volumes and rising prices, this conversation looks at what comes next, and how drinks brands need to respond.

Here’s what you’ll take away:

• Why GLP-1 injections are changing consumption patterns

• How appetite suppression is reshaping food and drink choices

• The move from snacking to nutrient density

• What younger consumers are cutting back on most

• How brands are adapting to rapid behavioural change

• The potential commercial impact of declining volumes

• Why understanding GLP-1 demographics matters for innovation

We hope you enjoy our little tipple.

LINKS

https://raisingtheglass.co.uk/

https://www.linkedin.com/in/miranda-m-ballard/

https://www.linkedin.com/in/rebecca-oliver-mooney-65730614/

Podcast production by https://www.gingerwizard.co.uk/

495204